Acting in capacity of Head of Finance and Controller supporting Sanofi's integration effortsLead FP&A, including forecasting, multi-year budgeting and strategic planning

Held role of Principle Accounting Officer and managed a team of over 10 individuals. Oversaw all aspects of corporate financial accounting, including, SEC reporting, SOX compliance, accounts payable, payroll, technical accounting functions, product revenue accounting, treasury/cash management, corporate insurance and income taxes.

> Corporate FP&A Director reporting to CFO. Responsibilities include directing the annual budget process, cash forecasting, producing Finance presentations for Board of Director meetings, and directing the quarterly forecasting process to provide revenue and OpEx guidance on quarterly earnings calls> Finance Business Partner providing cross-functional support primarily for Commercial and G&A teams, including supporting Business Development activities with financial modeling and due diligence, providing gross-to-net forecasts in support of the revenue forecasting process, building financial models that provide new insights that help shape our Commercial strategy, and other activities> Participate in monthly Strategic Business Review Meetings with senior leadership > Finance liaison to investor relations responsible for tracking analyst estimates, assisting with updating Finance script and Q&A for earnings calls, and assisting with responding to certain investor communications

General responsibilities include leading the SEC Reporting and technical accounting function as well as the Company's product revenue accounting process. I played a key role in developing the revenue recognition approach and related processes in connection with the commercial launch of NUPLAZID. Specifically:> Lead the external reporting function, including: preparation and filing of Forms 10-Q/10-K; reviewing XBRL; assisting with drafting of Proxy and preparation of Forms S-3/S-8/8-K; drafting earnings releases and Finance section of earnings call script.> Manage the annual audit and quarterly reviews.> Designed and implemented accounting processes and internal controls in connection with the launch of the Company's first commercial product, including documenting technical accounting memo and ensuring external auditors agreed with approach.> Lead the product revenue accounting process, including estimating all gross-to-net allowances, such as Medicare Part D Coverage Gap, Medicaid rebates, and chargebacks, and collaborating with Commercial Ops and IT to ensure necessary systems are in place for rev rec.> Forecasting gross-to-net.> Provided material assistance during public offerings that raised over $500M.> Manage Company’s SOX compliance efforts, including maintaining internal control narratives and matrices, implementing new controls as necessary and managing SOX consultants.> Perform and document all technical accounting research related to new and proposed accounting standards and complex accounting transactions and implement new policies as needed to adhere to new guidance.> Supported Investor Relations team with various IR activities, including tracking analyst estimates/consensus, providing responses to external financial-related inquiries, and reviewing press releases.> Responsible for determining Black-Scholes assumptions for equity accounting. > Drafted and rolled out new Travel and Expense policy that coincided with Concur implementation.

Cadence Pharmaceuticals was a commercial pharmaceutical company. My responsibilities included SEC Reporting & XBRL, revenue recognition (gross-to-net), Stock-Based Compensation, technical accounting research, and inventory accounting. Specifically:> Prepared 10Q/10K documents.> Managed XBRL component of financial reporting including selecting appropriate tags to ensure the Company was in compliance with XBRL requirements.> Worked closely with the Commercial team to calculate monthly gross-to-net revenue adjustments, including calculating a reasonable returns estimate for the Company’s first product, and drafting the related technical accounting memo, which allowed the Company to change from a sell-through to a sell-in revenue recognition model.> Responsible for inventory accounting, including performing related analysis such as LCM, over/under cost absorption, and estimating inventory in the channel.> Responsible for valuations of stock based compensation in accordance with ASC 718 for ISO/NQ stock options and restricted stock units.> Reviewed complex contracts to determine proper accounting treatment related to revenue recognition, leases, debt modifications, and other complex accounting areas.> Generated Cash Flow Statement, Equity Rollforward, Weighted Average Shares Outstanding, EPS, Impairment Analysis> Supported the Senior Director of Finance as the Company’s subject matter expert on technical accounting issues for both existing and new accounting standards.> Prepared technical accounting memos for use by management and the Company's auditors documenting the Company’s accounting position and treatment of accounting matters as they arose.> Proposed and implemented key SOX controls around revenue recognition. > Other responsibilities included, working closely with external auditors during the annual audit and quarterly reviews and presenting monthly financials to department heads.

> Managed financial statement audits of private and public companies, including supervision and coaching of junior staff.> Public company audits, including SOX Compliance testing.> Technical accounting research as needed.

> Analyzed financial data related to product tests to determine product’s success.> Contributed analysis instrumental to the implementation of a new pricing structure.> Made product pricing recommendations based on available competitor data and internal market research surveys.> Conducted in-depth analysis of underperforming markets to uncover areas of opportunity.> Generated weekly/monthly financial reports for internal management, including providing sales reports to support quarterly reviews and annual audits.